Experts are excitedly investigating retatrutide, a innovative drug created by Eli Lilly, as a potential advance in body management. Unlike many existing approaches, retatrutide is a double -action agonist targeting simultaneously GLP-1 and GIP, hormones that affect hunger and blood sugar regulat… Read More